Get the Stockscreener App
182.45
0.65%
1.18
After Hours:
182.45
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $182.45, with a volume of 581.59K.
It is up +0.65% in the last 24 hours and up +2.41% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$181.27
Open:
$182.81
24h Volume:
581.59K
Relative Volume:
1.27
Market Cap:
$8.47B
Revenue:
$3.03B
Net Income/Loss:
$237.44M
P/E Ratio:
36.27
EPS:
5.03
Net Cash Flow:
$450.04M
1W Performance:
+1.83%
1M Performance:
+2.41%
6M Performance:
-17.74%
1Y Performance:
-26.08%
1-Day Range:
$179.53
$184.39
1-Week Range:
$175.44
$184.39
52-Week Range:
$171.69
$256.85
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
182.45 | 8.47B | 3.03B | 237.44M | 450.04M | 5.03 |
|
ISRG
Intuitive Surgical Inc
|
604.12 | 215.18B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
240.37 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
88.54 | 43.79B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
247.79 | 36.40B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
344.69 | 25.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Teleflex Secures Contract with Vizient to Supply Vascular Access Products - MSN
Assenagon Asset Management S.A. Trims Stake in Teleflex Incorporated (NYSE:TFX) - MarketBeat
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Teleflex Incorporated (NYSE:TFX) Stock Holdings Lifted by Oak Thistle LLC - MarketBeat
Teleflex Seeks M&A - Marketscreener.com
Is Teleflex (NYSE:TFX) Using Too Much Debt? - Simply Wall St
December 19th Options Now Available For Teleflex (TFX) - Nasdaq
FY2024 EPS Estimates for Teleflex Cut by Zacks Research - MarketBeat
Zacks Research Has Pessimistic View of Teleflex Q4 Earnings - MarketBeat
Teleflex awarded short-term central venous catheters contract from Vizient - MSN
Teleflex awarded Short Term Central Venous Catheters contract from Vizient - GlobeNewswire
Teleflex Inc. stock outperforms competitors despite losses on the day - MarketWatch
How Is The Market Feeling About Teleflex? - Benzinga
Teleflex CEO Liam Kelly to Present at 43rd Annual J.P. Morgan Healthcare Conference - MyChesCo
Teleflex To Present At The 43rd Annual J.P. Morgan Healthcare Conference - Barchart
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Teleflex Stock: Is TFX Underperforming the Healthcare Sector? - MSN
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX) - Marketscreener.com
Teleflex Incorporated (NYSE:TFX) Shares Acquired by JPMorgan Chase & Co. - MarketBeat
These Battered S&P 500 Stocks Could Be Ripe for a Turnaround in 2025 - Investing.com
Teleflex Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Teleflex Stock: Is TFX Underperforming The Healthcare Sector? - Barchart
Should You Retain Teleflex Stock in Your Portfolio Right Now? - MSN
P/E Ratio Insights for Teleflex - Benzinga
Should You Think About Buying Teleflex Incorporated (NYSE:TFX) Now? - Simply Wall St
Franklin Resources Inc. Has $2.30 Million Stock Position in Teleflex Incorporated (NYSE:TFX) - MarketBeat
How Teleflex is Bringing Bucks Home More Quickly - AOL
Analysts Set Teleflex Incorporated (NYSE:TFX) Price Target at $252.50 - MarketBeat
Stifel Financial Corp Decreases Position in Teleflex Incorporated (NYSE:TFX) - MarketBeat
Teleflex Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Teleflex Is in Talks to Buy German Biotronik’s Stent Unit - MSN
Teleflex Inc. stock rises Monday, still underperforms market - MarketWatch
Top Surgical Sutures Companies - Verified Market Reports
Here's Why Teleflex (TFX) is a Strong Value Stock - Yahoo Finance
Teleflex price target lowered to $200 from $227 at Truist - Yahoo Finance
Teleflex stock touches 52-week low at $176.59 amid market challenges By Investing.com - Investing.com South Africa
Teleflex stock touches 52-week low at $176.59 amid market challenges - Investing.com Canada
Jane Street Group LLC Sells 5,350 Shares of Teleflex Incorporated (NYSE:TFX) - MarketBeat
Medical Metal Tubing Market Projected To Witness Substantial Growth, 2024-2031: Minitubes, Teleflex - EIN News
Urinary Incontinence Market Worth $19.34 Bn by 2030 | Berry Global, Teleflex Incorporated, Medtronic, - EIN News
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):